Genetically modified laboratory animals - What welfare problems do they face?

Journal of Applied Animal Welfare Science

Volumn 6, Issue 4, 2003, Pages 319-338

  Buehr, Mia ^a   Hjorth, J Peter ^a   Hansen, Axel Kornerup ^b   Sandøe, Peter ^b  

^a AARHUS UNIVERSITY   (Denmark)

^b UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

DNA; TRANSFORMING GROWTH FACTOR BETA;

ANIMAL BEHAVIOR; DISEASE MODEL; DNA MODIFICATION; EXPERIMENTAL ANIMAL WELFARE; GENE CONSTRUCT; GENE INSERTION; GENE MUTATION; GENE TARGETING; GENETIC DISORDER; GENETIC ENGINEERING; GENETIC MANIPULATION; GENETIC RECOMBINATION; GENETIC VARIABILITY; GENOTYPE; IN VITRO STUDY; MEDICAL RESEARCH; MUTAGENESIS; NONHUMAN; PHENOTYPE; PREDICTION; REVIEW; RODENT; ANIMAL; ANIMAL WELFARE; EXPERIMENTAL ANIMAL; TRANSGENIC ANIMAL;

ANIMALIA; RODENTIA;

ANIMAL WELFARE; ANIMALS; ANIMALS, GENETICALLY MODIFIED; ANIMALS, LABORATORY;

EID: 1642403816     PISSN: 10888705     EISSN: None     Source Type: Journal    
DOI: 10.1207/s15327604jaws0604_6     Document Type: Review

References (85)

1. Alagramam, K. N., Kwon, H. Y., Cacheiro, N. L. A., Stubbs, L., Wright, C. G., Erway, L. C., et al. (1999). A new mouse insertional mutation that causes sensorineural deafness and vestibular defects. Genetics, 152, 1691-1699.
2. Appleby, M. C., & Sandøe, P. (2002). Philosophical debate on the nature of well-being: Implications for animal welfare. Animal Welfare, 11, 283-294.
3. Balls, M. (1999). Does the use of transgenic animals raise particular welfare and ethical concerns? ATLA-Alternatives to Laboratory Animals, 27(Suppl. 1), 811-813.
4. Bhan, A. K., Mizoguchi, E., Smith, R. N., & Mizoguchi, A. (1999). Colitis in transgenic and knockout animals as models of human inflammatory bowel disease. Immunological Review, 169, 195-207.
5. Bosma, C. G., Custer, R. P., & Bosma, M. J. (1983). A severe combined immunodeficiency mutation in the mouse. Nature, 301, 527-530.
6. Broom, D. M. (1996). Animal welfare defined in terms of attempts to cope with the environment. Acta Agricultura Scandinavica. Section A, Animal Science, (Suppl. 27), 22-28.
7. Broom, D. M. (1997). Assessing the welfare of transgenic animals. In L. F. M. van Zutphen & M. van der Meer (Eds.), Welfare aspects of transgenic animals (pp. 58-67). Berlin: Springer.
8. Broom, D. M., & Johnson, K. G. (1993). Stress and animal welfare. London: Chapman & Hall.
9. Broome, R. L., Feng, L., Zhou, Q., Smith, A., Hahn, N., Matsui, S. M., et al. (1999). Non-invasive transgenic mouse genotyping using stool analysis. FEBS LETTERS, 462, 159-160.
10. Cheunsuk, S., Gerken, E., Osman, G., Hood, L., & Ladiges, W. (1999). Predictive parameters of joint disease in DBA/1 transgenic mice. Journals of Gerontology Series A: Biological Sciences and Medical Sciences, 54, B271-B275.
11. Cho, Y. H., Friedman, E., & Silva, A. J. (1999). Ibotenate lesions of the hippocampus impair spatial learning but not contextual fear conditioning in mice. Behavioural Brain Research, 98, 77-87.
12. Colledge, W. H., Ratcliff, R., Foster, D., Williamson, R., & Evans, M. J. (1992). Cystic fibrosis mouse with intestinal obstruction. Lancet, 340, 680.
13. Costa, P. (1997). Production of transgenic animals: Practical problems and welfare aspects. In L. F. M. van Zutphen & M. van der Meer (Eds.), Welfare aspects of transgenic animals (pp. 68-77). Berlin: Springer.
14. Crawley, J. N. (1999). Behavioral phenotyping of transgenic and knockout mice: Experimental design and evaluation of general health, sensory functions, motor abilities, and specific behavioral tests. Brain Research, 835, 18-26.
15. Crawley, J. N. (2000). What's wrong with my mouse? Behavioural phenotyping of transgenic and knockout mice. New York: Wiley-Liss.
16. Crawley, J. N., & Paylor, R. (1997). A proposed test battery and constellations of specific behavioral paradigms to investigate the behavioral phenotypes of transgenic and knockout mice. Hormones and Behaviour, 31, 197-211
17. Dorin, J. R., Dickinson, P., Alton, E., Smith, S. N., Geddes, D. M., Stevenson, B. J., et al. (1992). Cystic fibrosis in the mouse by targeted insertional mutagenesis. Nature, 359, 211-215.
18. Duncan, I. J. H. (1996). Animal welfare defined in terms of feelings. Acta Agricultura Scandinavica. Section A, Animal Science, (Suppl. 27), 29-35.
19. Duncan, M. K., Kozmik, Z., Cveklova, K., Piatigorsky, J., & Cvekl, A. (2000). Overexpression of PAX6(5a) in lens fiber cells results in cataract and upregulation of alpha 5 beta 1 integrin expression. Journal of Cell Science, 11, 3173-3185.
20. Eggan, K., Akutsu, H., Loring, J., Jackson-Grusby, L., Klemm, M., Rideout, W. M., et al. (2001). Hybrid vigor, fetal overgrowth, and viability of mice derived by nuclear cloning and tetraploid embryo complementation. Proceedings of the National Academy of Sciences of the United States of America, 98, 6209-6214.
21. Foltz, C. J., & Ullman-Cullere, M. (1999). Guidelines for assessing the health and condition of mice. Laboratory Animals, 28, 28-32.
22. Furukawa, T., Morrow, E. M., Li, T. S., Davis, F. C., & Cepko, C. L. (1999). Retinopathy and attenuated circadian entrainment in Crx-deficient mice. Nature Genetics, 23, 466-470.
23. Hahm, K. B., Im, Y. H., Parks, T. W., Park, S. H., Markowitz, S., Jung, H. Y., et al. (2001). Loss of transforming growth factor beta signaling in the intestine contributes to tissue injury in inflammatory bowel disease. Gut, 49, 190-198.
24. Hansen, A. K., Sandøe, P., Svendsen, O., Forsmann, B., & Thomsen, P. (1999). The need to refine the notion of reduction. In C. F. M. Hendriksen & D. B. Morton (Eds.), Humane endpoints in animal experiments for biomedical research (pp. 139-144). London: RSM.
25. Heinrichs, S. C., Min, H., Tamraz, S., Carmouche, M., Boehme, S. A., & Vale, W. W. (1997). Anti-sexual and anxiogenic behavioral consequences of corticotropin-releasing factor overexpression are centrally mediated. Psychoneuroendocrinology, 22, 215-224.
26. Ho, A. M., Johnson, M. D., & Kingsley, D. M. (2000). Role of the mouse ank gene in control of tissue calcification and arthritis. Science, 289, 265-270.
27. Horai, R., Saijo, S., Tanioka, M., Nakae, S., Sudo, K., Okahara, A., et al. (2000). Development of chronic inflammatory arthropathy resembling rheumatoid arthritis in interleukin 1 receptor antagonist-deficient mice. Journal of Experimental Medicine, 191, 313-320.
28. Hughes, B. O., Hughes, G. S., Waddington, D., & Appleby, M. C. (1996). Behavioural comparison of transgenic and control sheep: Movement order, behaviour on pasture and in covered pens. Animal Science, 6, 91-101.
29. Inui, A., Okita, M., Nakajima, M., Momose, K., Ueno, N., Teranishi, A., et al. (1998). Anxiety-like behavior in transgenic mice with brain expression of neuropeptide Y. Proceedings of the Association of American Physicians, 110, 171-182.
30. Jenkins, E. S., & Combes, R. D. (1999). The welfare problems associated with using transgenic mice to bioassay for bovine spongiform encephalopathy. Animal Welfare, 8, 421-431.
31. Kantachuvesiri, S., Haley, C. S., Fleming, S., Kurian, K., Whitworth, C. E., Wenham, P., et al. (1999). Genetic mapping of modifier loci affecting malignant hypertension in TGRmRen2 rats. Kidney International, 56, 414-420.
32. Karolyi, I. J., Burrows, H. L., Ramesh, T. M., Nakajima, M., Lesh, J. S., & Seong, E. (1999). Altered anxiety and weight gain in corticotropin-releasing hormone-binding protein-deficient mice. Proceedings of the National Academy of Sciences of the United States of America, 96, 11595-11600.
33. Lai, L. X., Kolber-Simonds, D., Park, K. W., Cheong, H. T., Greenstein, J. L., Samuel, G. S., et al. (2002). Production of alpha-1, 3-galactosyltransferase knockout pigs by nuclear transfer cloning. Science, 295, 1089-1092.
34. Lee, S., Khare, S. D., Griffiths, M. M., Luthra, H. S., & David, C. S. (2000). HLA-B27 transgenic mice are susceptible to collagen-induced arthritis: Type II collagen as a potential target in human disease. Journal of Human Immunology, 61, 140-147.
35. Lyon, M. F., & Searle, A. G. (1989). Genetic variants and strains of the laboratory mouse. New York: Oxford University Press.
36. Maas-Szabowski, N., Szabowski, A., Stark, H. J., Andrecht, S., Schorpp-Kistner, M., Angel, P., et al. (2001). Organotypic cocultures with genetically modified mouse fibroblasts as a tool to dissect molecular mechanisms regulating keratinocyte growth and differentiation. Journal of Investigative Dermatology, 116, 816-820.
37. Mani, P. (1998). Animal welfare problems concerning the use of transgenic animals. ALTEX-Alternativen zu Tierexperimented, 15, 32-33.
38. Masood, E. (1997). Pressure grows for inquiry into welfare of transgenic animals. Nature, 388, 311-312.
39. Mayeux-Portas, V., File, S. E., Stewart, C. L., & Morris, R. J. (2000). Mice lacking the cell adhesion molecule Thy-1 fail to use socially transmitted cues to direct their choice of food. Current Biology, 2000, 68-75.
40. Meisler, M. (1992). Insertional mutations of "classical" and novel genes in transgenic mice. Trends in Genetics, 8, 341-344.
41. Mepham, T., & Crilly, R. E. (1999). Bioethical issues in the generation and use of transgenic farm animals. ATLA-Alternatives to Laboratory Animals, 27(Suppl. 1), 847-855.
42. Mertens, C., & Rulicke, T. (1999). Score sheets for the monitoring of transgenic mice. Animal Welfare, 8, 433-438.
43. Mirochnitchenko, O., Prokopenko, O., Palnitkar, U., Kister, I., Powell, W. S., & Inouye, M. (2000). Endotoxemia in transgenic mice overexpressing human glutathione peroxidases. Circulation Research, 87, 289-295.
44. Mombaerts, P., Iacomini, J., Johnson, R. S., Herrup, K., Tonegawa, S., & Papaioannou, V. E. (1992). RAG-1 deficient mice have no mature B and T lymphocytes. Cell, 68, 869-877.
45. Moore, C. J., & Mepham, T. B. (1995). Transgenesis and animal welfare. ATLA, 23, 380-397.
46. Morrell, J. M. (1999). Techniques of embryo transfer and facility decontamination used to improve the health and welfare of transgenic mice. Laboratory Animals, 33, 201-206.
47. Muller, W., Kuhn, R., & Rajewsky, K. (1991). Major histocompatibility complex class II hyperexpression on B cells in interleukin 4 transgenic mice does not lead to B cell proliferation and hypergammaglobulinemia. European Journal of Immunology, 21, 921-925.
48. Mullins, L. J., Morley, S. D., & Mullins, J. J. (1996). Transgenics and essential hypertension. Journal of Human Hypertension, 10, 627-631.
49. Nelson, R. J., & Chiavegatto, S. (2000). Aggression in knockout mice. ILAR Journal, 41, 153-162.
50. Ogonuki, N., Inoue, K., Yamamoto, Y., Noguchi, Y., Tanemura, K., Suzuki, O., et al. (2002). Early death of mice cloned from somatic cells. Nature Genetics, 30, 253-254.
51. Paine, R., Preston, A. M., Wilcoxen, S., Jin, H., Siu, B. B., Morris, S. B., et al. (2000). Granulocyte-macrophage colony-stimulating factor in the innate immune response to Pneumocystis carinii pneumonia in mice. Journal of Immunology, 164, 2602-2609.
52. Podolsky, D. K. (1997). Lessons from genetic models of inflammatory bowel disease: Acta gastro-enterol. Belgica, 60, 163-165.
53. Porter, D. G. (1992). Ethical scores for animal experiments. Nature, 356, 101-102.
54. Reddig, P. J., Dreckschmidt, N. E., Zou, J., Bourguignon, S. E., Oberley, T. D., & Verma, A. K. (2000). Transgenic mice overexpressing protein kinase C epsilon in their epidermis exhibit reduced papilloma burden but enhanced carcinoma formation after tumor promotion. Cancer Research, 60, 595-602.
55. Rideout, W. M., Eggan, K., & Jaenisch, R. (2001). Nuclear cloning and epigenetic reprogramming of the genome. Science, 293, 1093-1098.
56. Rochford, J., Beaulieu, S., Rousse, I., Glowa, J. R., & Barden, N. (1997). Behavioral reactivity to aversive stimuli in a transgenic mouse model of impaired glucocorticoid (Type II) receptor function: Effects of diazepam and FG-7142. Psychopharmacology, 132, 145-152.
57. RondiReig, L., Dubreuil, Y. L., Martinou, J. C., Delhaye-Bouchaud, N., Caston, J., & Mariani, J. (1997). Fear decrease in transgenic mice overexpressing bcl-2 in neurons. Neuroreport, 8, 2429-2432.
58. Schieve, L. A., Meikle, S. F., Ferre, C., Peterson, H. B., Jeng, G., & Wilcox, L. S. (2002). Low and very low birth weight in infants conceived with use of assisted reproductive technology. New England Journal of Medicine, 346, 731-737.
59. Schmitteckert, E. M., Prokop, C. M., & Hedrich, H. J. (1999). DNA detection in hair of transgenic mice - A simple technique minimizing the distress of the animals. Laboratory Animals, 33, 385-389.
60. Sharpe, R. M., Maguire, S. M., Saunders, P. T. K., Millar, M. R., Russell, L. D., Ganten, D., et al. (1995). Infertility in a transgenic rat due to impairment of cytoplasmic elimination and sperm release from the Sertoli cells. Biology of Reproduction, 53, 214-226.
61. Shinkai, Y., Rathbun, G., Lam, K. P., Oltz, E. M., Stewart, V., Mendelsohn, M., et al. (1992). Rag-2 deficient mice lack mature lymphocytes owing to inability to initiate V(D)J rearrangement. Cell, 68, 855-867.
62. Smeyne, R. J., Klein, R., Schnapp, A., Long, L. K., Bryant, S., Lewin, A., et al. (1994). Severe sensory and sympathetic neuropathies in mice carrying a disrupted Trk/NGF receptor gene. Nature, 36, 246-249.
63. Smith, R. S., Roderick, T. H., & Sundberg, J. P. (1994). Microphthalmia and associated abnormalities in inbred black mice. Laboratory Animal Science, 44, 551-560.
64. Smithies, O. (1993). Animal models of human genetic diseases. Trends in Genetics, 9, 112-116.
65. Snouwaert, J. N., Brigman, K. K., Latour, A. M., Malouf, N., Boucher, R., Smithies, O., et al. (1992). An animal model for cystic fibrosis made by gene targeting. Science, 257, 1083-1088.
66. Steele, E. C., Wang, J. H., Lo, W. K., Saperstein, D., Li, X. L., & Church, R. L. (2000). Lim2(To3) transgenic mice establish a causative relationship between the mutation identified in the Lim2 gene and cataractogenesis in the To3 mouse mutant. Molecular Vision, 6, 85-94.
67. Strohle, A., Poettig, M., Barden, N., Holsboer, F., & Montkowski, A. (1998). Age- and stimulus-dependent changes in anxiety-related behaviour of transgenic mice with GR dysfunction. Neuroreport, 9, 2099-2102.
68. Tabuchi, Y., Ohta, S., Arai, Y., Kawahara, M., Ishibashi, K., Sugiyama, N., et al. (2000). Establishment and characterization of a colonic epithelial cell line MCE301 from transgenic mice harboring temperature-sensitive simian virus 40 large T-antigen gene. Cell Structure & Function, 25, 297-307.
69. Tanaka, S., Oda, M., Toyoshima, Y., Wakayama, T., Tanaka, M., Yoshida, N., et al. (2001). Placentomegaly in cloned mouse concepti caused by expansion of the spongiotrophoblast layer. Biology of Reproduction, 65, 1813-1821.
70. Tamashiro, K. L. K., Wakayama, T., Akutsu, H., Yamazaki, Y., Lachey, J. L., Wortman, M. D., et al. (2002). Cloned mice have an obese phenotype not transmitted to their offspring. Nature Medicine, 8, 262-267.
71. Taurog, J. D., & Hammer, R. E. (1996). Experimental spondyloarthropathy in HLA-B27 transgenic rats. Clinical Rheumatology, 15, 22-27.
72. Tronche, F., Kellendonk, C., Kretz, O., Gass, P., Anlag, K., Orban, P. C., et al. (1999). Disruption of the glucocorticoid receptor gene in the nervous system results in reduced anxiety. Nature Genetics, 23, 99-103.
73. Tumminia, S. J., Clark, J. I., Richiert, D. M., Mitton, K. P., Duglas-Tabor, Y., Kowalak, J. A., et al. (2001). Three distinct stages of lens opacification in transgenic mice expressing the HIV-1 protease. Experimental Eye Research, 72, 115-121.
74. van der Meer, M., Baumans, V., Olivier, B., & van Zutphen, B. L. M. (2001). Impact of transgenic procedures on behavioral and physiological responses in postweaning mice. Physiology and Behaviour, 73, 133-143.
75. van der Meer, M., Costa, P., Baumans, V., Olivier, B., & van Zutphen, B. (1999). Welfare assessment of transgenic animals: Behavioural responses and morphological development of newborn mice. ATLA-Alternatives to Laboratory Animals, 27(Suppl. 1), 857-868.
76. van der Meer, M., Rolls, A., Baumans, V., Olivier, B., & van Zutphen, L. F. M. (2001). Use of score sheets for welfare assessment of transgenic mice. Laboratory Animals, 35, 379-389.
77. van der Meer, M., & van Zutphen, L. F. M. (1997). Use of transgenic animals and welfare implications. In L. F. M. van Zutphen & M. van der Meer (Eds.), Welfare aspects of transgenic animals (pp. 78-89). Berlin: Springer.
78. Voigt, J. P., Rex, A., Bader, M., & Fink, H. (2000). From genotype to phenotype - Behavior of the transgenic rat TGR(mRen2)27 as an example. Reviews in the Neurosciences, 11, 37-45.
79. Wakayama, T., Perry, A. C. F., Zuccotti, M., Johnson, K. R., & Yanagimachi, R. (1998). Full-term development of mice from enucleated oocytes injected with cumulus cell nuclei. Nature, 394, 369-374.
80. Watanabe, M., Ueno, Y., Yamazaki, M., & Hibi, T. (1999). Mucosal IL-7-mediated immune responses in chronic colitis-IL-7 transgenic mouse model. Immunological Research, 20, 251-259.
81. Wei, F., Wang, G. D ., Kerchner, G. A., Kim, S. J., Xu, H. M., Chen, Z. F., et al. (2001). Genetic enhancement of inflammatory pain by forebrain NR2B overexpression. Nature Neuroscience, 4, 164-169.
82. Weiss, S. M., Lightowler, S., Stanhope, K. J., Kennett, G. A., & Dourish, C. T. (2000). Measurement of anxiety in transgenic mice. Reviews in the Neurosciences, 11, 59-74.
83. Wolf, E., & Wanke, R. (1997). Growth hormone overproduction in transgenic mice: Phenotypic alterations and deduced animal models. In L. F. M. van Zutphen & M. van der Meer (Eds.), Welfare aspects of transgenic animals (pp. 26-47). Berlin: Springer.
84. Young, L. E., Sinclair, K. D., & Wilmut, I. (1998). Large offspring syndrome in cattle and sheep. Reviews of Reproduction, 3, 155-163.
85. Zahm, J. M., Gaillard, D., Dupuit, F., Hinnrasky, J., Porteous, D., Dorin, J. R., et al. (1997). Early alterations in airway mucociliary clearance and inflammation of the lamina propria in CF mice. American Journal of Physiology & Cell Physiology, 41, C853-C859.